Concepts (141)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Quantitative Trait Loci | 9 | 2024 | 2136 | 1.230 |
Why?
|
Single-Cell Analysis | 7 | 2024 | 2536 | 0.630 |
Why?
|
Immunologic Memory | 2 | 2024 | 1374 | 0.600 |
Why?
|
Th17 Cells | 1 | 2021 | 786 | 0.470 |
Why?
|
Tuberculosis, Pulmonary | 1 | 2021 | 836 | 0.460 |
Why?
|
Mycobacterium tuberculosis | 2 | 2024 | 1909 | 0.450 |
Why?
|
Synovial Membrane | 3 | 2024 | 512 | 0.410 |
Why?
|
T-Lymphocyte Subsets | 2 | 2019 | 1812 | 0.390 |
Why?
|
Peru | 3 | 2024 | 888 | 0.350 |
Why?
|
Genetic Predisposition to Disease | 5 | 2024 | 18074 | 0.250 |
Why?
|
Arthritis, Rheumatoid | 4 | 2024 | 3743 | 0.240 |
Why?
|
Gene Expression Regulation | 5 | 2024 | 11895 | 0.230 |
Why?
|
Genome | 2 | 2023 | 1753 | 0.230 |
Why?
|
Chromatin | 2 | 2024 | 2979 | 0.190 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 2 | 2024 | 812 | 0.190 |
Why?
|
Autoimmune Diseases | 2 | 2024 | 2248 | 0.190 |
Why?
|
Genome-Wide Association Study | 6 | 2024 | 12803 | 0.170 |
Why?
|
Neonatal Screening | 1 | 2024 | 619 | 0.170 |
Why?
|
Receptors, Antigen, T-Cell | 3 | 2024 | 2570 | 0.160 |
Why?
|
Death Certificates | 1 | 2020 | 172 | 0.160 |
Why?
|
Psoriasis | 2 | 2024 | 922 | 0.160 |
Why?
|
Macrophages | 2 | 2024 | 5772 | 0.140 |
Why?
|
Immunophenotyping | 2 | 2019 | 1865 | 0.140 |
Why?
|
Biotechnology | 1 | 2019 | 284 | 0.140 |
Why?
|
T-Lymphocytes | 3 | 2024 | 10256 | 0.140 |
Why?
|
B-Lymphocytes | 2 | 2024 | 4782 | 0.110 |
Why?
|
Protein Interaction Domains and Motifs | 1 | 2015 | 446 | 0.100 |
Why?
|
Dendritic Cells | 1 | 2024 | 2745 | 0.100 |
Why?
|
Complementarity Determining Regions | 2 | 2024 | 154 | 0.100 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2024 | 1884 | 0.100 |
Why?
|
Tuberculosis | 1 | 2024 | 2009 | 0.090 |
Why?
|
Genetic Testing | 1 | 2024 | 3594 | 0.090 |
Why?
|
Lymphocytes | 1 | 2019 | 2601 | 0.090 |
Why?
|
Genomics | 2 | 2024 | 5925 | 0.090 |
Why?
|
Socioeconomic Factors | 2 | 2021 | 7842 | 0.090 |
Why?
|
Residence Characteristics | 1 | 2020 | 2116 | 0.090 |
Why?
|
Cytokines | 2 | 2023 | 7417 | 0.080 |
Why?
|
Research Design | 2 | 2023 | 6204 | 0.080 |
Why?
|
Peptides | 2 | 2022 | 4331 | 0.070 |
Why?
|
Lymphocyte Activation | 3 | 2024 | 5500 | 0.070 |
Why?
|
Polymorphism, Single Nucleotide | 5 | 2024 | 16039 | 0.070 |
Why?
|
Humans | 23 | 2024 | 765926 | 0.070 |
Why?
|
Software | 1 | 2021 | 4462 | 0.070 |
Why?
|
Sex Factors | 1 | 2021 | 10611 | 0.070 |
Why?
|
CD8-Positive T-Lymphocytes | 3 | 2024 | 4641 | 0.070 |
Why?
|
Opioid-Related Disorders | 1 | 2020 | 2177 | 0.060 |
Why?
|
Chromosome Mapping | 2 | 2024 | 4617 | 0.060 |
Why?
|
Brain Mapping | 1 | 2020 | 6598 | 0.060 |
Why?
|
Phenotype | 4 | 2024 | 16714 | 0.060 |
Why?
|
Age Factors | 1 | 2021 | 18382 | 0.060 |
Why?
|
Disease Progression | 1 | 2021 | 13614 | 0.060 |
Why?
|
Bipolar Disorder | 1 | 2021 | 5128 | 0.050 |
Why?
|
Case-Control Studies | 1 | 2021 | 22228 | 0.050 |
Why?
|
Cell Proliferation | 1 | 2019 | 10426 | 0.050 |
Why?
|
Lymphocyte Subsets | 1 | 2024 | 313 | 0.050 |
Why?
|
Depressive Disorder, Major | 1 | 2021 | 4805 | 0.050 |
Why?
|
Transcription Factor AP-1 | 1 | 2024 | 322 | 0.050 |
Why?
|
Cell Shape | 1 | 2024 | 372 | 0.050 |
Why?
|
Brain | 2 | 2020 | 27179 | 0.050 |
Why?
|
Metabolism, Inborn Errors | 1 | 2024 | 291 | 0.050 |
Why?
|
Mutant Proteins | 1 | 2024 | 486 | 0.050 |
Why?
|
T-Box Domain Proteins | 1 | 2024 | 469 | 0.050 |
Why?
|
Plasma Cells | 1 | 2024 | 596 | 0.040 |
Why?
|
Chromosomes | 1 | 2023 | 578 | 0.040 |
Why?
|
Proteins | 1 | 2015 | 5994 | 0.040 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 2023 | 792 | 0.040 |
Why?
|
Follow-Up Studies | 1 | 2021 | 39228 | 0.040 |
Why?
|
Genotype | 2 | 2024 | 13026 | 0.040 |
Why?
|
Amino Acid Sequence | 2 | 2024 | 13398 | 0.040 |
Why?
|
Genetic Variation | 2 | 2024 | 6612 | 0.040 |
Why?
|
Bronchoalveolar Lavage Fluid | 1 | 2021 | 755 | 0.040 |
Why?
|
Mental Disorders | 1 | 2018 | 6870 | 0.040 |
Why?
|
Epigenesis, Genetic | 2 | 2024 | 3816 | 0.040 |
Why?
|
Metabolic Diseases | 1 | 2024 | 686 | 0.040 |
Why?
|
Young Adult | 2 | 2021 | 59857 | 0.040 |
Why?
|
Sequence Analysis, RNA | 1 | 2024 | 2036 | 0.030 |
Why?
|
Autoimmunity | 1 | 2024 | 1354 | 0.030 |
Why?
|
Aged, 80 and over | 1 | 2021 | 59496 | 0.030 |
Why?
|
Adolescent | 2 | 2021 | 88811 | 0.030 |
Why?
|
Natural Killer T-Cells | 1 | 2019 | 319 | 0.030 |
Why?
|
Middle Aged | 4 | 2024 | 223016 | 0.030 |
Why?
|
Male | 6 | 2024 | 363815 | 0.030 |
Why?
|
Adult | 4 | 2024 | 223088 | 0.030 |
Why?
|
Killer Cells, Natural | 1 | 2024 | 2206 | 0.030 |
Why?
|
Cell Nucleus | 1 | 2024 | 2864 | 0.030 |
Why?
|
Female | 6 | 2024 | 396141 | 0.030 |
Why?
|
Gyrus Cinguli | 1 | 2021 | 1116 | 0.030 |
Why?
|
Cluster Analysis | 1 | 2021 | 2717 | 0.030 |
Why?
|
Aged | 3 | 2024 | 171163 | 0.030 |
Why?
|
Mammals | 1 | 2020 | 1126 | 0.030 |
Why?
|
Fibroblasts | 1 | 2024 | 4161 | 0.030 |
Why?
|
Sequence Analysis, DNA | 1 | 2024 | 4780 | 0.030 |
Why?
|
Colon | 1 | 2021 | 1796 | 0.030 |
Why?
|
Epigenomics | 1 | 2018 | 958 | 0.030 |
Why?
|
Child | 1 | 2021 | 80568 | 0.030 |
Why?
|
Cell Lineage | 1 | 2022 | 2573 | 0.030 |
Why?
|
Mass Spectrometry | 1 | 2020 | 2194 | 0.030 |
Why?
|
Inflammation | 2 | 2023 | 10843 | 0.030 |
Why?
|
HSP90 Heat-Shock Proteins | 1 | 2015 | 422 | 0.030 |
Why?
|
Lung Diseases, Interstitial | 1 | 2021 | 940 | 0.020 |
Why?
|
Enhancer Elements, Genetic | 1 | 2018 | 1363 | 0.020 |
Why?
|
Leukocytes, Mononuclear | 1 | 2019 | 1852 | 0.020 |
Why?
|
Biopsy | 1 | 2023 | 6766 | 0.020 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2024 | 4405 | 0.020 |
Why?
|
RNA | 1 | 2021 | 2716 | 0.020 |
Why?
|
Genome, Human | 1 | 2023 | 4443 | 0.020 |
Why?
|
Transcription, Genetic | 1 | 2024 | 7599 | 0.020 |
Why?
|
Gene Regulatory Networks | 1 | 2018 | 1748 | 0.020 |
Why?
|
Skin | 1 | 2023 | 4481 | 0.020 |
Why?
|
Cause of Death | 1 | 2020 | 3715 | 0.020 |
Why?
|
Computational Biology | 1 | 2021 | 3562 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2024 | 14643 | 0.020 |
Why?
|
HeLa Cells | 1 | 2015 | 3070 | 0.020 |
Why?
|
Amyotrophic Lateral Sclerosis | 1 | 2020 | 1481 | 0.020 |
Why?
|
Colitis, Ulcerative | 1 | 2021 | 1912 | 0.020 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2021 | 2157 | 0.020 |
Why?
|
Crohn Disease | 1 | 2021 | 2281 | 0.020 |
Why?
|
Escherichia coli Proteins | 1 | 2015 | 1056 | 0.020 |
Why?
|
Poverty | 1 | 2020 | 2714 | 0.020 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2022 | 3111 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2024 | 9525 | 0.020 |
Why?
|
Computer Simulation | 1 | 2021 | 6251 | 0.020 |
Why?
|
Massachusetts | 1 | 2020 | 8882 | 0.020 |
Why?
|
Immunity, Innate | 1 | 2019 | 3078 | 0.020 |
Why?
|
Mice, Inbred C57BL | 1 | 2024 | 22327 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2015 | 4257 | 0.020 |
Why?
|
Homeodomain Proteins | 1 | 2015 | 2430 | 0.020 |
Why?
|
Mice | 2 | 2024 | 81782 | 0.020 |
Why?
|
Models, Molecular | 1 | 2015 | 5377 | 0.020 |
Why?
|
Tumor Suppressor Proteins | 1 | 2015 | 2795 | 0.020 |
Why?
|
Transcription Factors | 1 | 2024 | 12129 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2024 | 26380 | 0.010 |
Why?
|
Analgesics, Opioid | 1 | 2020 | 3834 | 0.010 |
Why?
|
Escherichia coli | 1 | 2015 | 4210 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2020 | 9600 | 0.010 |
Why?
|
Lung | 1 | 2021 | 10046 | 0.010 |
Why?
|
Algorithms | 1 | 2021 | 14064 | 0.010 |
Why?
|
Animals | 2 | 2024 | 168735 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2020 | 26282 | 0.010 |
Why?
|
United States | 1 | 2024 | 72909 | 0.010 |
Why?
|
Mutation | 1 | 2020 | 30192 | 0.010 |
Why?
|
Concepts
(141)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(41)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_